PreSize Surgery Transforming brain surgery with AI-driven decision-support
- Coordinator
- Oxford Heartbeat Ltd, United Kingdom
- Runs
- 1 October 2026 to 30 September 2028
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 101315187
What the project is doing
In the project's own words, from its summary on CORDIS.
Brain aneurysms, affecting 5% of the global population, pose significant health and economic challenges. Ruptures lead to a 50% fatality rate and severe neurological deficits in 66% of survivors. Current minimally invasive interventions, such as stent-assisted coiling, rely on manual, experience-based techniques for device selection and placement. These methods are prone to errors, causing high rates of complications, repeat surgeries, and wasted stents costing ~€10,000 each.
The economic burden in Europe alone exceeds €4.7B annually. Oxford Heartbeat’s PreSize Surgery revolutionises neurovascular care by combining preoperative 3D simulation with real-time intraoperative guidance powered by generative AI. This solution fuses patient-specific imaging with live surgical data to enhance precision, detect deployment deviations, and provide actionable insights during procedures. By increasing surgical accuracy to 95%, reducing complications, and minimising device wastage, PreSize Surgery transforms neurovascular procedures, setting a new standard in minimally invasive surgery and unlocking €550M+ annual market opportunities.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Oxford Heartbeat Ltd | London | United Kingdom | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS